Skip to Main Content

The company that filed nearly a dozen lawsuits alleging drug makers devised schemes in which nurses were used illegally to promote medicines and boost prescriptions has filed blistering responses to a federal government effort to dismiss the cases.

In court filings, the National Health Care Analysis Group took the U.S. Department of Justice to task for misunderstanding the issues raised in its whistleblower lawsuits, maintained the government never fully investigated the allegations, and suggested a conflict of interest in the Executive Branch may have influenced the decision to have the cases tossed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!